Burdens, Evolving Management of Alopecia: Expert Review
We speak with prominent alopecia researchers and experts to gain insights into the burden associated with hair loss as well as standard and new treatment options for alopecia.
Alopecia
Reliability Assessment of Alopecia-Related Most-Viewed Videos on TikTok
Researchers sought to investigate the reliability and characteristic content of the most viewed alopecia-related videos on TikTok focusing on diagnoses, content type, and content creators.
Study Investigating Oral JAK Inhibitor for Alopecia Areata Meets Endpoint
CTP-543 is an investigational oral selective inhibitor of JAK1 and JAK2.
Vitamin D Deficiency Not Linked to Frontal Fibrosing Alopecia Development
Patients with frontal fibrosing alopecia (FFA) do not need to have vitamin D levels tested as deficiency is unlikely tied to the pathogenesis of FFA.
Olumiant Approved for Severe Alopecia Areata
The approval was based on data from the phase 2/3 BRAVE-AA1 and phase 3 BRAVE-AA2 trials, which included adults with severe alopecia areata.
Association Between Alopecia Areata and COVID-19
Literature on clinical studies and reports investigating the association between new-onset alopecia areata or the exacerbation of preexisting alopecia areata following infection with SARS-CoV-2 are reviewed.
Ritlecitinib Treatment for Alopecia Areata Shows Early Response Rates
The efficacy of ritlecitinib in treating patients with alopecia areata is assessed.
Minoxidil vs Conventional Androgenic Alopecia Treatments
The efficacy of various doses of minoxidil, dutasteride, and finateride for the treatment of male androgenic alopecia (AGA) is evaluated.
Dermatology in Skin of Color: From Unmet Needs to Culturally Competent Care
Disparities in dermatology and the role of ethnic skin centers in addressing these issues are discussed with Angela Lamb, MD.
Hair Loss in Women is More Than a Cosmetic Concern
Less than half of women experiencing hair loss have genetic origins as the cause; possible causes and treatments are reviewed.
- Loading...
Loading...
Next post in News
Loading... 
Loading...